InvestorsHub Logo
Followers 3
Posts 35
Boards Moderated 0
Alias Born 07/15/2015

Re: None

Wednesday, 09/30/2015 9:30:02 AM

Wednesday, September 30, 2015 9:30:02 AM

Post# of 403156
It's great news.

TWO drugs will be in phase 3 beginning of year with kevetrin in phase2 sometime in 2016

TWO drugs Will most likely get FDA approval in 2017

Remember the number 1 barrier to approval are SERIOUS AE
2nd is efficacy
P2 is the most difficult to pass.

Odds of approval in P3 vary but generally are 70-80% for drugs submitted for FDA approval
As far as I'm concerned we are good to go.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News